Production of a cytokine with interleukin 3-like properties and cytokine-dependent proliferation in human autologous mixed lymphocyte reaction by unknown
PRODUCTION OF A CYTOKINE WITH
INTERLEUKIN 3-LIKE PROPERTIES AND CYTOKINE-
DEPENDENT PROLIFERATION IN HUMAN AUTOLOGOUS
MIXED LYMPHOCYTE REACTION
BY RYUJI SUZUKI, SATSUKI SUZUKI, TETSU TAKAHASHI, AND
KATSUO KUMAGAI
From the Department ofMicrobiology, Tohoku University School ofDentistry,
Sendai 980, Japan
The proliferative response elicited from cultured human T lymphocytes by
the presence of autologous non-T lymphocytes has been described as being an
autologous mixed lymphocyte reaction (AMLR)' by many laboratories (1, 2) .
This reactivity and the ability of murine, rat, guinea pig, or rabbit T lymphocytes
to proliferate in response to syngeneic non-T stimulator cells in vitro (the
syngeneic mixed lymphocyte reaction [SMLR]) are thought to represent a self-
recognitive mechanism that might be important in regulating the cellular inter-
actions involved in the generation of normal immune responses (2, 3) . B lympho-
cytes, macrophages, or dendritic cells may stimulate this T lymphocyte response
(2, 4) . The responding cells belong to the helper/inducer class of T cells (5-7) .
The reaction is dependent on the expression of I region-associated (la) antigens,
inasmuch as the addition of haplotype-specific anti-la sera to the cultures inhibits
the reactions (8, 9) .
The nature of the major antigenic stimulus in the AMLR has, however, been
disputed . It has been proposed that previous exposure of responding T cells to
foreign antigens such as sheep red blood cells (SRBC) and fetal calfserum (FCS),
which are generally used during cell purification or culture, could be responsible
for the observed proliferative response (10, 11) . On the other hand, several data
derived from human, murine, or guinea pigsystems argue against this possibility
and indicate that the AMLR or SMLR is a true T cell proliferative response,
which is directed to la antigens on the stimulator cells (12-14) .
Nevertheless, there is another argument against the specific nature of the
AMLR or SMLR, and this is the disagreement concerning what soluble mediators
are involved in theAMLR . Several investigators (15-18) have demonstrated the
production ofT cell growth factor (or interleukin 2, [IL-2]) in the humanAMLR
or mouseSMLR . However, the relationship between the IL-2, if detected, in the
murine SMLR and the proliferative response in the reaction is unknown (17,
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18) . In addition, others (19, 20) have demonstrated production of some helper
factors distinct from IL-2 that facilitate the development of cytotoxic cells, but
have failed to demonstrate the production of a significant amount of IL-2 in the
murine SMLR.
We (21) have recently demonstrated that the murine SMLR that uses re-
sponder T cells and stimulator non-T cells, which were prepared and cultured
in the absence of any xenogeneic protein stimulation, induces a significant
proliferative response and produces a hematopoietic growth regulator, interleu-
kin 3 (IL-3), but not IL-2. These studies have also demonstrated that the murine
SMLR may be primarily a cell interaction, in which the non-T cells stimulate
helper T cells to produce IL-3, which in turn induces proliferation of IL-3-
responding cells, but not mature T cells, that appear to have a phenotype of
relatively early precursors in lymphocyte differentiation.
The purpose of this study was to carefully analyze the human AMLR, partic-
ularly examining whether the proliferative response in the AMLR system can be
induced by using cell separation methods and culture in the absence of xenoan-
tigens, and what kinds of soluble factors regulating the reaction are produced.
The results provide evidence that AMLR in the absence of any added foreign
antigens generates no IL-2 production, but does generate production of a
cytokine with murine IL-3-like properties, which mediates cell proliferation in
the reaction.
Materials and Methods
Preparation ofResponderandStimulator Cellsin AMLR.
￿
Mononuclear cellswere isolated
from the venous blood of healthy normal volunteers by Ficoll-Isopaque gradient centrif-
ugation, as described (22), except that autologous human serum (AHS), was used instead
of FCS in making the Ficoll-Isopaque gradient. The separated mononuclear cells were
washed three times with RPMI 1640 medium (Gibco Laboratories, Grand Island, NY)
and were suspended with culture medium containing 20% AHS (RPMI/AHS).
To separate nonadherent responder T cellsand adherent stimulator cells, a 20-ml glass
syringe was packed with 5 g nylon wool (NY) (Leuko-Pak leukocyte filter, Travenol
Laboratories, IL), drained with RPMI/AHS, and equilibrated in a 37°C incubator for 60
min. To this column, 1-3 X 108 mononuclear cells in 2-4 ml of RPMI/AHS medium
were added drop by drop. The column was then washed with an additional 1 ml of warm
medium. The column was then incubated at 37°C for 60 min in a 5% CO2/95% air
humidified atmosphere. The nonadherent cells were eluted with 40-60 ml of warm
RPMI/AHS media at a flow rate of one drop per second, and used as responder cells (23).
Responder cell fractions thus obtained contained >82% T cells as determined by the
reaction with T3 monoclonal antibody and a FACS analyzer (Becton, Dickinson & Co.,
Sunnyvale, CA), and <0.4% B cells as detected by surface immunoglobulins.
To obtain stimulator cells, NY-adherent cells were recovered by transferring the NY
wool to a Petri dish containing AHS-free RPMI 1640 medium and teasing it apart with
forceps. The cells collected in the centrifuge tube were then spun for 10 min at 200 g
and suspended in the RPMI/AHS medium. The cells were treated with mitomycin C
(MMC) at 25 tug/10' cells for 60 min at 37 °C and then used as stimulator cells. These
non-T cell fractions contained ^-60% surface Ig+ B cells, 15-25% monocytes, and <8%
T lymphocytes, the rest being non-T, non-B cells.
Cultured ConditionsforAMLR.
￿
RPM I 1640 medium was supplemented with 20% heat-
inactivated (56°C, 45 min) fresh AHS. In addition, culture medium contained 80 MM L-
glutamine (Sigma Chemical Co., St. Louis, MO) and 5 X 10-5 M 2-mercaptoethanol.
These conditions were used throughout the experiments except where otherwise stated.
To obtain the culture supernatants for interleukin and interferon (IFN) assays, 2.5 X 1061684
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responder T cells plus 2 .5 X 106 MMC-treated stimulator cells were incubated in 24-well
flat-bottomed culture plates (Nunc, Roskilde, Denmark) with a total volume of 2.0 ml .
Cells and supernatants were recovered by centrifugation at 200 g for 10 min. The
supernatants were passed through 0.2-jm filters (Millipore Corp., Bedford, MA), and
then tested for IL-2, IL-3, and IFN activities.
For determination of DNA replication, 200 wl of the cell suspensions were cultured in
96-well round-bottomed microtiter plates (Falcon Labware, Oxnard, CA) at 37°C. 18 h
before harvest, 0.5 ACi oftritiated thymidine (specific activity, 5 Ci/mmol; the Radiochem-
ical Centre, Amersham, England) was added to each well, and the amount of radioactive
uptake was measured. Data are expressed as the mean counts per minute and standard
deviation of triplicate cultures.
Allogeneic MLR Assays. Allogeneic MLR was tested by using NY-nonadherent re-
sponder cells from a donor and MMC-treated NY-adherent stimulator cells from another
allogeneic donor, both of which were prepared as described above. Fresh autologous
serum from a responder donor, but not FCS was used for the cell separation medium .
The cultured cells and their supernatants were also obtained as described in AMLR.
Assays for IL-3 Activity.
￿
The assay for IL-3-like activity was performed as previously
described with the murine IL-3-dependent cell line, 32Dcl (24-26). Briefly 104 32Dcl
cells were cultured in a final volume of 200 Al in the presence of several concentrations
of material being tested for IL-3 activity. After 21-24 h of culture at 37°C, each culture
was pulsed overnight with 0.5 uCi of ['H]TdR, harvested onto glass fiber filters, and
counted for radioactive thymidine uptake. The results are expressed as the mean and
standard deviation (SD) of specific ['H]TdR incorporation (cpm) in triplicate cultures, as
described (26).
Mouse IL-3 was purifed from WEHI-3 culture supernatants by DEAE cellulose chro-
matography followed by chromatography on Sephacryl S-200 column and a reverse-phase
high-performance liquid chromatographic system, as previously described (26). This
partially purified IL-3 had a specific activity of 1 .2 ng/U measured by proliferation of
32Dcl cells, and was used as a standard preparation for IL-3 activity.
IL-2 and IL-2 Assays.
￿
Human recombinant IL-2 (rIL-2) with a specific activity of 1 .0
X 10' U/mg (27) was supplied by Shionogi Pharmaceutical Co., Ltd. (Osaka, Japan) and
used as a standard IL-2. The IL-2-dependent NK cell line NK-7 (27, 28) used in routine
assays for the detection of IL-2 activity was maintained in RPMI 1640 containing 10%
FCS and 50 U/ml of rIL-2. Another IL-2-dependent T cell line, CTLL-2 (29), was used
for some experiments and maintained in RPMI 1640/10% FCS plus 1 % sodium pyruvate
and 50 U/ml of rIL-2.
Using these cell lines, the assays of IL-2 activity were carried out as previously described
(30). Results are expressed as the mean and SD of specific ['H]TdR incorporation (cpm)
in triplicate cultures, as described (30). The data are then expressed in units (U) by
comparing experimental probit data with that obtained with the use of a standard rIL-2
preparation. 1 U of a standard IL-2 is the concentration necessary to stimulate 50% of
the maximum ['H]TdR uptake by NK-7 cells (30). IL-2 levels of 0 .05 U/ml or greater
are significant by probit analysis. Murine monoclonal antibody against human rIL-2 was
supplied by Shionogi Pharmaceutical Co. Ltd. One unit of anti-rIL-2 was defined as the
dose required to neutralize one unit of rIL-2 (Yoshida et al., manuscript in preparation).
IFN-y, anti-IFN-y Serum, and IFN Assay.
￿
Human recombinant IFN-y with a specific
activity of 1 .0 X 10' U/mg and monoclonal antibody against recombinant human INF-y
(27) were kindly supplied by Shionogi Pharmaceutical Co. The 1:10,000 antiserum
neutralized natural and recombinant human IFN-y at 10 U/ml, but the antiserum, even
undiluted, could not neutralize human recombinant IFN-a or IFN-,B at 10 U/ml.
Antiviral activity was assayed on human WISH cells by the 50% plaque reduction
method and expressed as reciprocal values of the dilutions that reduce the numbers of
virus plaques by 50%, as previously described (21).
Monoclonal Reagents.
￿
Monoclonal antibodies ofthe OK series, i.e., OKT3 (anti-panT),
OKT4 (anti-helper/inducer T), and OKT8 (anti-suppressor/cytotoxic T), were pur-
chased from Ortho Diagnostics (Raritan, NJ). Cells reactive with these antibodies wereSUZUKI ET AL.
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enumerated by an indirect immunofluorescence and FACS. A monoclonal antibody to
HLA-DR antigens (OKIal) was purchased from Ortho Diagnostics. This antibody is
directed against the complex of both chains of DR antigens and it binds to B cells and
macrophages but not to normal T cells.
Elimination ofOKT4 or OKT8 Cell Population by Complement-mediated Lysis.
￿
Lysis of T
cell populations by monoclonal antibodies was done as previously described (31) with a
minor modification . Briefly, test cells were treated wtih 0.1 ml of OKT4 or OKT8
antibody (100 )Ag of protein/ml) and 1 .0 ml of 1 :10-diluted rabbit C (Lo-Tox-H rabbit
complement, Cederlane Laboratories, Ltd., Hornby, Ontario, Canada) in RPMl/AHS for
45 min at 37 °C. The surviving cells were then washed three times, counted, and tested
for their response to AMLR stimulators. When T cell-enriched responder fractions were
treated with anti-T4 and C, residual cells consisted of>90% T3+ and T8+ cells, with <2%
T4+ cells. Treatment of cells with anti-T8 and C yielded preparations consisting of>90%
T3+ and T4+ cells and <3% T8+ cells.
General Biochemical Procedures.
￿
Protein determinations throughout the purification
employed were based on the OD at 280 nm. The AMLR culture fluids were condensed
by ultracentrifugation using the Diaflow membrane YM-5 (Amicon Corp., Lexington,
MA). Gel filtration analysis of these condensed AMLR culture fluids was performed by
using a Superose 12 column of the fast protein liquid chromatography (FPLC) system
(Pharmacia Fine Chemicals, Uppsala, Sweden). DEAE cellulose chromatography was done
by using a MonoQ column of the FPLC system (Pharmacia Fine Chemicals). For both
chromatographies, the condensed AMLR culture fluids were dialyzed extensively against
equilibration buffer, and applied to the column. The Superose 12 column was equilibrated
and developed with 10 mM phosphate-buffered saline (PBS, pH, 7 .2), and 0.5 ml of
effluents at each fraction were collected and then assayed for cell growth-stimulating
activities. The M,. ofthe activities in this gel filtration were calibrated by using the standard
markers, ferritin (M, 440,000), aldolase (Mr 158,000), bovine serum albumin (Mr 67,000),
and ribonuclease A (M, 13,700). The MonoQ column was eluted with a linear gradient
of 0-0.5 M NaCl. Fractions of 0.5 ml were collected and the biological activities of each
were determined.
Bone Marrow Cultures.
￿
Bone marrow was obtained from healthy volunteers by aspi-
ration from the iliac crest. Light-density cells were separated by Ficoll-Isopaque density
gradient centrifugation. Cells were washed with the buffer and suspended at 5 X 106
cells/ml in RPMI 1640 medium containing 10% FCS. To 100 /1 ofcell suspensions seeded
in wells of a 96-well microtiter plate (Falcon Labware) was added 100 Al of test materials
at twofold dilutions and then incubated at 37°C for 72 h. Cultures were harvested onto
glass fiber filter papers and counted by the liquid scintillation technique for thymidine
incorporation as described.
Results
DNA Replication in AMLR in the Absence ofForeign Proteins.
￿
Table I shows the
results ofexperiments, in which NY-nonadherent T lymphocytes from six healthy
volunteers were cultured with MMC-treated autologous NY-adherent stimulator
cells in a culture medium containing AHS for 5 d and then examined for DNA
replication. With all the cases, the responder cells cocultured with the stimulator
cells generated significant DNA replication. The cultures of responder cells alone
produced no definite DNA replication in the absence of stimulator cells, nor was
there any significant DNA replication in the cultures of stimulator cells alone .
These results indicate that the cultivation of responder T cells with adherent
non-T stimulator cells in the absence ofany xenogeneic protein antigens produces
a significant AMLR. When graded numbers of nonadherent responder cells (2
X 106 to 1 .25 X 105) were cultured with 5 X 105 of MMC-treated stimulator1686 PRODUCTION OF INTERLEUKIN 3-LIKE CYTOKINE
TABLE I
AMLR in Healthy Individuals
Respondercells (5 X 105)from each individual were incubatedwith MMC-treated
stimulator cells (5 X 105) in a 200-A1 culture medium containing AHS for 5 d
and examined for DNA replication. Responder cells or stimulated cells alone
were also cultured for 5 d.
Effect ofAnti-DR Monoclonal Antibody in Induction ofAMLR andAllo-MLR
TABLE II
* Responder nonadherent T cells (5 X 105)from a donorwere incubatedwith theadherent stimulator
cells (5 X 105) from an autologous or allogeneic donor in the presence of anti-DRantibody at the
final dilutions indicated for 5 d, andthen examined for their ['H]TdR incorporations. Each value
is the mean ± standard deviation of threedeterminations.
Percent inhibition of medium controls.
cells, the maximum replication was obtained with 5 X 105 responder cells (data
not shown).
Inhibition of the AMLR Response by Monoclonal Anti-DR Antibody.
￿
It has been
reported that in the SMLR or AMLR, as well as the allogeneic (alto) MLR, the
class II major histocompatibility complex (MHC) gene products (ta or HLA-DR
antigens) are critically important in stimulating this response (8, 9, 13, 14). It
has also been shown that the responder cells in human AMLR are T4+,T8-
helper/inducer type of T cells (32, 33). We therefore examined whether the
AMLR induced in our systems also involves an interaction between the HLA-
DR+ stimulator cells and responder/helper T cells, by using monoclonal antibod-
ies. As shown in Table 11, when the responder T cells were incubated with
autologous or allogeneic stimulator cells in the presence of anti-DR monoclonal
antibody, the proliferative response in AMLR, as well as in alto-MLR, was
significantly inhibited by the antibody in a dose-related fashion.
Subsequently, nonadherent T cells were treated with complement and T4 or
T8 monoclonal antibody, and examined for DNA replication in response to
autologous stimulator adherent cells (Table III). Nonadherent T cells that had
been depleted of T4 but not of T8 cells produced an extremely reduced DNA
Donors
['H]TdR
Responder+ stimula-
tor
incorporation (cpm)
Responder Stimulator
RS 49,653 t 2,264 672 ± 307 265 ± 54
MI 50,012 ± 7,356 1,448 ± 639 198 ± 17
YT 34,792 ± 4,081 747 ± 319 318 ± 199
KH 43,281 ± 4,930 519 ± 266 215 ± 88
TT 30,986 ± 2,736 398 ± 101 164 ± 47
RS 40,861 ± 708 601 ± 52 291 ± 86
Dilutions ofanti-
DR added
AMLR ['H]TdR incor-
poration*
cpm
Inhibition*
%
Allo-MLR ['H]TdR in-
corporation*
cpm
Inhibition$
Medium 46,097 ± 8,527 - 75,664 ± 4,363 -
1:10 8,051 t 2,901 82.5 9,633 ± 1,749 87.2
1:100 29,756 t 3,046 35.4 37,627 ± 10,209 50.2
1:1,000 43,666 t 10,551 5.2 65,263 ± 7,209 13.8SUZUKI ET AL.
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TABLE III
Abrogation ofProliferative Response ofResponder Cells in AMLR
after Treatment with Complement and Anti-T4 but Not Anti-T8
Monoclonal Antibody
The C-treated, or Cplus anti-OKT4- or OKT8-treated nonadherent T
cells were reconstituted to 10' lymphocytes/ml, and used as responder
cells in AMLR. [sH]TdR incorporation was measured on day 5 of
culture.
* Each value is the mean ± standard deviation of three cultures.
$ Percent inhibition of medium control.
replication, indicating that the T4'T8- helper/inducer T cells are involved in
DNA replication in AMLR as previously described (31, 32).
Production of a Lymphokine with IL-3-like Properties but Not IL-2 or IFN in
AMLR. We next examined, in addition to DNA replications, production of IL-
2 and IFN, and the murine IL-3-like activity assayed by 32Dcl cell line, in the
AMLR supernatants of the coculture of responder T cells with stimulator non-
T cells in a culture medium containing AHS. These results were compared with
those for allo-MLR, in which the responder T cells from the same donor were
incubated with the stimulator cells isolated from another donor. The results of
a representative experiment shown in Fig. 1 A indicate that DNA replication in
AMLR was demonstrable on day 3 after incubation, and reached a peak on day
5, decreasing thereafter. Regardless of this active proliferative response, no
minimal levels of IL-2 (0 .05 U/ml) and IFN (2 U/ml) could be detected during
the entire culture periods, but the activity stimulating the growth of a murine
IL-3-dependent cell line 32Dc1 was found. The activity to a minimal level was
detected as early as 1 d after incubation in AMLR, increased with time, and
reached the maximum (18 X IOs cpm) on day 5. On the other hand, in alloMLR
(Fig. 1 B), IL-2 at ^-10 U/ml and IFN at 80 U/ml could be induced. Production
of the activity that stimulated 32Dcl cells with a maximum of 5 X 10s cpm on
day 5 was also induced.
To confirm that there was no production of IL-2 in the AMLR, the AMLR
supernatants on day 3 were condensed into a 0 .1 vol by a Centricon membrane
and tested for IL-2 activity in their serial dilutions using CTLL-2 and NK-7 cell
lines, and for activity stimulating the murine IL-3-dependent cell line 32Dcl
(Fig. 2). The human rIL-2 served as controls (Fig. 2). The condensed culture
fluids were found to contain an increased amount of murine IL-3-like activity
stimulating the target, but no IL-2 assessed by either CTLL-2 or NK-7, both of
which were responsible for rIL-2 stimulation . With the culture fluids harvested
on day 1, 2, or 4, no IL-2 activity was detected. Also, no IFN activity was found
in any condensed AMLR culture fluids (data not shown).
No Involvement ofIL-2 and IFN-y in DNA Replication in the AMLR.
￿
We further
examined whether IL-2 and IFN, which might be produced in the AMLR to
Treatment [sH]TdR incorporation*
cpm
Inhibition$
C 42,230 ± 2,793 -
Anti-T4 + C 7,739 ± 1,155 81.7
Anti-T8 + C 47,931 ± 4,458 016)88
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FIGURE 1 .
￿
A time course of DNA replication and lymphokine production in (A) AMLR and
(B)allo-MLR. Responder NY-nonadherent T cells (2.5 x 106) from a donor were incubated
with 2.5 x 106 stimulator NY-adherent cells of an (A) autologous or (B) allogeneic donor in
2.0 ml of RPMI/AHS at 37°C for 11 d. At the indicated time after incubation, activity to
stimulate 32Dcl cells ("), IL-2 activity by NK-7 cell growth (/), and IFN activity (A) in the
culture supernatants were measured. [sH]TdR incorporation by the cultured cells (O) were
assayed in a 200-wl culture system described in Materials and Methods. Values represent the
means ± standard deviation of triplicate cultures.
undetectable levels, are involved in the development of DNA replication in
AMLR. Specific monoclonal antibodies directed against human rIL-2 or human
rIFN-y were added to the culture, and then tested for their effect on the
proliferative response. The cultures of a11oMLR in the presence of anti-IL-2 or
anti-IFN-y served as controls (Table IV). The results clearly showed that both
2.5-10 U/ml of anti-rIL-2 and 25-50 U/ml of anti-rIFN-y did not affect theE
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FIGURE 2.
￿
Function of AMLR supernatants in maintaining murine IL-3-dependent cell lines
32Dcl but not IL-2-dependent cell lines NK-7 or CTLL-2. 10-fold condensed AMLR super-
natants (day 3) (0), or human rIL-2 (5 U/ml) (p) were titrated into the cultures and the
proliferative response was measured. Thevalues represent the means of triplicate cultures.
TABLE IV
Effect ofAnti-IL-2 and Anti-IFN--y Monoclonal Antibodies in Induction of
AMLR and Allo-MLR
1689
Responder cells(5 X 105) from a donor were cultured with 5 x 105 adherent stimulator cells from
an autologous (AMLR) or allogeneic (AlloMLR) donor in the 200 ul of culture medium in the
absence or presence of anti-IL-2 or anti-IFN-y monoclonal antibodies at the titers indicated. On
day 5, [5H]TdR incorporation by the cultured cells was assayed. Values represent the means ±
standard deviation of triplicate cultures.
* Numbersin parentheses represent percentinhibition of medium control.
proliferative response of AMLR, whereas they definitely diminished the prolif-
eration ofcells in the allo-MLR in a dose-related fashion. These results indicate
that DNA replication in AMLR, unlike allo-MLR, did not involve either IL-2 or
IFN--y in the reaction.
IL-3-like Activity as a Growth Factor Responsible for AMLR.
￿
We further exam-
ined whether the IL-3-like activity produced in the AMLR culture fluids is a
growth factor responsible for the AMLR-induced DNA replication, which was
found to be independent of IL-2 and IFN. First, we harvested the AMLR culture
Donor Incubation with:
[5H]TdR
AMLR
incorporation (cpm ± SD)
Allo-MLR
Medium 52,194 ± 6,013 71,358 ± 16,254
A Anti-IL-2 (10 U/ml) 48,618 ± 1,625 (7)* 14,385 ± 4,209 (80)
(2 U/ml) 52,164 ± 5,366 (<1) 19,068 ± 7,586 (73)
Anti-IFN-y (50 U/ml) 50,393 ± 2,369 (3) 27,348 ± 13,609 (62)
(25 U/ml) 50,624 ± 2,634 (3) 39,981 ± 12,033 (43)
Medium 43,754 ± 5,322 ND
B Anti-IL-2 (10 U/ml) 42,253 ± 7,061 (3) ND
(5 U/ml) 42,958 ± 5,274 (2) ND
(2.5 U/ml) 49,581 ± 1,097 (0) ND
Anti-IFN-y (50 U/ml) 44,214 ± 2,550 (0) ND1690
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TABLE V
Proliferative Response ofPBL to the AMLR CultureSupernatants
AMLR su-
The culture fluids in AMLR on day 4 were harvested, and 50 juI of the
culture fluids was added to 150 KI of culture medium containing unfrac-
tionated, NY-nonadherent, and NY-adherent responder mononuclear
cells in wells of a 96-well microplate, cultured for 60 h, labeled with ['H]-
TdR, and then examined for their ['H]TdR incorporation 12 h after
incubation. The values represent the means ± standard deviation of
triplicate cultures.
fluids on day 3, added them to peripheral blood mononuclear cells (unfraction-
ated) and their adherent and nonadherent fractions, and incubated for 3 d to
examine for their proliferative responses (Table V). The nonadherent fraction,
and unfractionated cells to a lesser extent, but not adherent mononuclear cells,
responded to the AMLR culture fluids with proliferation.
Next, the AMLR culture fluids on day 5 were condensed and subjected to
chromatography on FPLC-Superose 12. The effluents were tested for activity
supporting the proliferation of 32Dcl and activity inducing the proliferation of
nonadherent responder cells (Fig. 3). The results show that both activities were
eluted from the column as a single peak at fraction 31 (corresponding to an Mr
of 15,000-28,000). Neither IL-2 nor IFN was found in any effluents of AMLR
culture fluids from the column (data not shown).
The AMLR culture fluids concentrated by an Amicon membrane were also
applied to a chromatography on a MonoQ column of the DEAE-type FPLC
system. The column was subsequently eluted with a linear concentration gradient
of NaCI. As shown in Fig. 4, a major factor that induces proliferation of 32Dcl
did not bind to the column and was eluted in the run-through fractions. The
major activity inducing the replication of AMLR responder cells was eluted
together with the IL-3-like activity. Both activities inducing the growth of 32Dc1,
and nonadherent responder cells were also eluted as a minute fraction from the
column by 0.2-0.3 M NaCl. Both fractions had no apparent effect on the
proliferation of IL-2-responding CTLL-2 or NK-7 cells. The mitogenic tests for
murine thymocytes revealed that the factors had no IL-1-like mitogenic activity
(34 and data not shown).
Furthermore, we examined whether the IL-3-like factor acted to support
replication of the growing cells in the AMLR. The cells in AMLR on day 5 were
rigorously washed with the buffer, incubated further for 2 d in the FPLC-
MonoQ column-purified factor, and then examined for the factor-dependent
growth of test cells (Table VI). The results clearly showed that the cells during
Mononuclear cells pernatant
added
(25%)
['H]TdR incorporation
(cpm)
Unfractionated + 3,986± 646
- 220 ± 35
NY-nonadherent + 16,092 ± 2,730
- 241 ± 54
NY-adherent + 1,776 ± 734
- 271 ± 66c
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FIGURE 3.
￿
Detection of activity-stimulating 32Dcl cells or nonadherent responder mononu-
clear cells in AMLR in the effluents from an FPLC-Superose 12 column of AMLR culture
fluids. 0.5 ml of 10-fold concentrated AMLR culture supernatants by a Centricon membrane
was subjected to Superose 12 chromatography and developedwith 0.01 M phosphate buffer
(pH 7.2). The effluents were dialyzed against RPMI medium and then tested for IL-3-like
activity by 32Dcl cell growth (0) and activity stimulating nonadherent responder cells in
AMLR (Q). K, standard M, markers in thousands. The values represent the mean ± standard
deviation in triplicate assays.
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FIGURE 4 . Detection of IL-3-like activity and activity-stimulating nonadherent responder
mononuclear cells in the effluents from FPLC-MonoQ column of AMLR culture fluids. 0.5
ml of 10-fold concentrated AMLR culture supernatants (on day 5) were subjected to chro-
matography on the FPLC-MonoQ column and developed with a 0.01-0.5 M NaCl gradient
in 0.01 M sodium phosphate buffer (pH 7.2). The effluents, after dialyzation against RPMI
1640 medium, were tested for stimulation of 32Dcl cell growth (") and activity-stimulating
nonadherent respondercellsin AMLR (0). Values arethemean counts perminute in triplicate
assays.
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TABLE VI
Supporting Effect oftheFactor on the Growth ofResponding Cells
during AMLR Cultures
The cultured cells on day 5 of AMLR were harvested and washed three
times with the buffer. The cellsharvested (5 X 105)were cultured further
for 2 d in fresh RPMI/AHS in the absence or presence of the factor
partially purified by FPLC MonoQcolumn at theindicated concentrations
and then examined for [sH]TdR incorporation.
AMLR culture continued to extensively grow in the medium containing the
factor in a dose-dependent fashion, although they also replicated to a much lesser
extent in the fresh medium without addition of the factor.
Growth-stimulating Effect of the Factor on Bone Marrow Cells.
￿
Finally, we ex-
amined whether this IL-3-like factor had any effect on stimulation of the bone
marrow cell, as did the murine IL-3 (35). The bone marrow cells isolated from
a healthy donor were incubated with a medium containing factor, partially
purified by MonoQ column chromatography, in a serial dilution for 60 h, and
then examined for their proliferative responses (Fig. 5) . The results clearly
showed that the factor, in a dose-related fashion, stimulated bone marrow cell
proliferation. It was also shown that the proliferative response of bone marrow
cells to the factor was much higher than that of peripheral blood lymphocytes,
as was the response of murine bone marrow cells to the murine IL-3 (35). The
experiments were repeated with bone marrow cells from five other donors with
similar results.
Discussion
in the present study, we initially focused attention on the protection of AMLR
from the sensitization of test cells by xenogeneic antigen stimulation. The
problem of FCS as mitogen and antigen has been well recognized for a long
time. FCS induces blastogenic and cytotoxic responses in unseparated human
peripheral blood lymphocytes (PBL)(36). SRBC, which have generally been used
for separation of T and B cells, can also stimulate an antigen-specific plaque-
formingcell (PFC) response in unseparated PBL in the absence of any nonspecific
stimulating agent (37). Therefore, in our experiments we used the technique of
passage through NY column to separate responder T cells and stimulator non-
T cells. Autologous human serum, but not FCS or allogeneic human serum, was
always used for the cell separation and culture. By using these techniques, we
have shown that NY-nonadherent responder cells generated a significant DNA
replication in response to NY-adherent stimulator cells, without any background
proliferative response in the absence of stimulator cells.
Concentrations of AMLR-IL-3
added (%) [5H]TdR incorporation (cpm ± SD)
25 29,754 ± 756
12.5 25,868 ± 1,935
6.25 22,015 ± 1,638
3.1 18,740 ± 1,638
1.6 14,419 ± 1,207
- 9,759 ± 826^ 6
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FIGURE 5.
￿
Proliferative response of bone marrow cells to the factor. The serial dilutions of
active fraction (100 pl) from the MonoQ column of AMLR culture fluids (") or 100 ul of
RPMI/AHS medium (O) were added to 100 itd of 2.5 X 106/ml bone marrow cells in wells of
a 96-well microtiter plate and incubatedfor 60 h. The cellswere then examined for ['H]TdR
incorporation (12-h-incubation). Values are the mean ± standard deviation in triplicate
cultures.
Earlier studies by Huber et al. (10) and Kagan and Choi (11) reported that, in
the absence of stimulation by SRBC or FCS, the human AMLR did not take
place, according to the criteria of T cell proliferation. The response could be
observed only in cultures that had either been supplemented with FCS or
contained lymphocytes that had been previously exposed to FCS or SRBC. A
more recent study by Naides et al, (38) has, however, shown that nonadherent
T cell populations purified by nylon filtration or plastic adherence produce an
AMLR even in the absence of exposure to xenoantigens. Although the reasons
for the discrepancies among these studies, including ours, remain unknown, it is
possible that the differences in the culture conditions or cell populations used
might cause these discrepancies. For example, the NY-adherent non-T cells that
we used as a stimulator were the same as those used by Kagan and Choi (11), but
responder cells used in the study by Naides et al. (38), as well as in our study,
were NY-purified nonadherent cells, which were different from the unseparated
peripheral mononuclear cells used by Kagan and Choi.
The AMLR assayed in the absence of xenoantigen stimulation in the present
study, as well as allo-MLR, was shown to be dependent on the expression of DR
antigens and mediated by T4',T8- helper/inducer T cells. These results are
consistent with previous reports by other investigators showing that the human
AMLR (7, 9, 32, 33) or murine SMLR (5, 8, 14) may represent helper/inducer
T cell activation mediated through a receptor for self-la antigens. The AMLR
in our study, however, regardless of the significant DR antigen-dependent
response of helper T cells, generated no production of IL-2, in contrast to1694
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definite levels of IL-2 production in allo-MLR . Earlier studies by Palacios and
Moller (15) demonstrated the production of IL-2 in an AMLR that contained
lymphocytes that had been separated by rosetting using SRBC. Exposure of
lymphocytes to SRBC alone stimulates significant T cell proliferation and PFC
responses in the human AMLR (11). Therefore, it is not surprising that under
such conditions, IL-2 production takes place. In the murine syngeneic MLR
system, Lattime et al. (17, 18) reported thatTcell proliferation could be detected
in cultures containing FCS but not in those supplemented with syngeneic mouse
serum. However, small amounts of IL-2 were produced independent of the
presence of FCS. Some other reports on human autologous (11) and murine
syngeneic (19, 20) MLR have, however, failed to demonstrate the production of
IL-2. Our recent work (21) has shown that the murine syngeneic MLR, as well
as the human AMLR shown in the present study, generated no IL-2 production,
regardless of a significant DNA replication in the absence of any xenogeneic
protein stimulation.
We showed further that DNA replication induced in the human AMLR was
not inhibited by addition of a specific antiserum against human rIL-2, which
could suppress DNA replication in the allo-MLR . Specific IFN--Y antiserum,
which was shown to suppress the allo-MLR, as described in the murine systems
(39), also did not affect the human AMLR. These results may also support the
results showing no production ofIL-2 and IFN-y in the AMLR.
In the present study, we have found that a cytokine, which can stimulate the
murine IL-3-dependent cell line 32Dc1, is produced in the AMLR soon after
culture and before the onset ofproliferative response. The major activity in the
AMLR culture fluids had an M, of 15,000-28,000 in gel filtration, which was
similar to an M, of human IL-2 (40), but it had no activity to stimulate IL-2-
dependent cell lines NK-7 or CTLL-2. The major activity did not bind to FPLC-
MonoQ column (DEAE type), to which IL-2 bound (40), and was recovered in
the run-through fractions, as was the murine IL-3 (26, 35). It was also found
that the AMLR culture fluids contained a soluble factor that could stimulate
proliferation of the fresh nonadherent mononuclear cells. The factor, when
applied to the Superose 12 and FPLC-MonoQ columns was eluted from both
columns together with the IL-3-like activity. These results strongly suggest that
the factor may be a major activity responsible for the cell proliferation in the
AMLR.
Murine IL-3 is a multilineage hematopoietic growth regulator that initiates
the proliferation and differentiation of multipotential stem cells, leading to the
production of all the major blood cell types (35, 41-43). It is produced by
mitogen- or antigen-activated T lymphocytes and by a number of continuous
cell lines (35). Purified murine IL-3 exhibited a growth-supporting effect on IL-
3-dependent myelomonocytic, lymphoid, or mast cell lines but not on any IL-2-
dependent cell lines. IL-3 derived from the WEHI-3 cell cultures has been
purified to homogeneity by a combined method using different kinds of chro-
matography (43). The protein isglycosylated and theMr ofthe major glycosylated
species was estimated to be 28,000 (43). Recently, cDNA clones specifying the
IL-3 derived from the WEHI-3 cells have been isolated, and a polypeptide of
166 amino acids, including a putative signal peptide, has been deduced from theSUZUKI ET AL.
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cDNA (44). At present, molecules equivalent to murine IL-3 have not been
isolated from the human lymphocyte cultures. The factor found in the human
AMLR culture fluids in this study had a murine IL-3-like property in the activity
supporting the growth ofmurine IL-3-dependent cell line, 32Dcl, butnot in that
supporting the growth of IL-2-dependent cell lines NK-7 or CTLL-2. It had no
IL-2 or IFN activity . Nor was there any IL-1 activity in the factor. The factor
strongly stimulated freshly isolated bone marrow cells, as did the murine IL-3
(35, 41, 42). Although human and murine colony stimulating factors (CSF), as
well as murine IL-3, could stimulate bone marrow cells (45, 46), 32Dc1 cells
responsible for murine IL-3 and the IL-3-like factor in the present study did not
respond to human recombinant granulocyte/macrophage CSF (data not shown).
Some physicochemical properties, such as elution patterns in DEAE chromatog-
raphy, were similar to those of murine IL-3 (42, 43). These results strongly
suggest that the factor found in this study may be a humanmolecule(s) equivalent
to murine IL-3 or a molecule closely related to it. Asimilar activity was found in
the allo-MLR culture fluids (Fig. 1) and other antigen-specific lymphocyte
cultures (data not shown). Further purification and the physicochemical proper-
ties of the factors are being examined.
In our recent experiments (21), it has been shown that in the murine SMLR,
Thy-1+, Lyt-1+,2- helper/inducer T cells produce IL-3 in response to NY-
adherent stimulator cells, and that the IL-3 induces proliferation ofThy-1-, Lyt-
1-,2-, sIg, asialo GMI-negative cells, but not of IL-2-responsive Thy-1+ or
asialo GMI-positive cells. These results suggest that the murine SMLR may be
primarily a proliferative reaction to the IL-3 of early precursors in lymphocyte
or hematopoietic cell differentiation. Although further experiments are under-
way that will determine the responder cells to the factor and proliferating cells
in the human AMLR, our unpublished observations indicate that although the
producing cells of IL-3 in response to the IL-3-like factor are T3', T4+, T8-,
T11' helper cells, the responding cells to the factor appear to be cells with low
density but lacking a typical phenotype of T cells or NK cells (Suzuki et al.,
manuscript in preparation). Therefore, we propose that the AMLR (SMLR) in
human and murine systems may be a phenomenon, in which self-la antigens on
the stimulator cells stimulate helper/inducer T cells to produce IL-3 or IL-3-
related molecules but not IL-2, which in turn induce proliferation of the
responding cells to the factor. These responding cells are not IL-2-responsive
mature Tcells or NK cells.
It remains unknown whether the AMLR and the selective production of IL-3
or IL-3-like molecules have a physiologic significance in regulation of normal
immune responses in vivo. As to a possible role in lymphocyte differentiation,
however, IL-3 has been shown to stimulate early events in the differentiation of
T cells such as Thy-1 expression on the cell (35) or to augment the primary
cytolytic T lymphocyte response to allogeneic tumor cells (47). It is presumed,
therefore, that the AMLR may play a role at least in T and B lymphocyte
differentiation in the immune responses, acting through production of IL-3. IL-
3 has also been shown to stimulate premature B cells to produce Ig (48).
It has also been reported by several investigators that the human or murine
AMLR produces soluble factors (19, 20, 49-51) that were shown to play a helper1696
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or suppressor role in regulation of certain immune responses. Some structural
homologies among certain of these factors and the IL-3-like factor found in the
present study might be anticipated, although further elucidation will require
additional biological and biochemical analysis.
Summary
The autologous mixed lymphocyte reaction (AMLR) was assayed in a medium
containing fresh autologous serum, by using nylon-adherent stimulator cells and
nonadherent responder T cells, which were prepared from human peripheral
blood mononuclear cells in the absence of fetal calf serum (FCS) to avoid any
sensitization to xenogeneic protein antigens. DNA replication without a back-
ground proliferative response was induced by stimulator cells in the responder
cells. The addition of monoclonal anti-HLA-DR antibody to the culture or
treatment of the responder cells with complement plus anti-T4 but not anti-T8
monoclonal antibody suppressed the AMLR, suggesting that this specific AMLR
involves an interaction between HLA-DR antigens and helper/inducer T cells.
Regardless of this specific DNA replication, the AMLR generated no production
of interleukin 2 (IL-2) and interferon y (IFN-y), both of which could be found
in the allogeneic (allo) MLR. In addition, DNA replication in the AMLR was not
inhibited by the addition of specific antisera for IL-2 and IFN-y, both of which
significantly inhibited the DNA replication in allo-MLR.
The AMLR was accompanied by production of a soluble factor, which could
stimulate the proliferation of murine interleukin 3 (IL-3)-dependent cell line
32Dcl but not the proliferation of IL-2-dependent cell lines. This factor was also
found to be responsible for proliferation of responder nonadherent cells in the
AMLR. It strongly stimulated bone marrow cells, as did the murine IL-3 . The
factor had an Mr range, as determined by gel filtration, of 15,000-28,000, but
it did not bind to fast protein liquid chromatography (FPLC)-MonoQ column.
Thus, the factor is distinguishable from IL-2 in physicochemical or biological
properties, but similar to murine IL-3 . These results suggest that the human
AMLR may be primarily a phenomenon in which non-T cells mediated by the
HLA-DR antigens on the cell stimulate helper/inducer T cells to produce a
lymphokine with IL-3-like properties, but no IL-2, which in turn stimulates the
factor-dependent cells to proliferate.
We thank Shionogi Pharmaceutical Co., Ltd., for the supply of recombinant human IL-2
and anti-IL-2 andanti-IFN-'Y monoclonal antibodies.
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